Henrik Juuel
Business
Orexo
Sweden
Biography
EVP and Chief Financial Officer Holds current position since 2013. M.Sc., University of Aarhus, Denmark, and University of Leuven, Belgium. Previous appointments: Extensive relevant experience from senior international management positions within the life science industry, including senior finance positions for Novo Nordisk and positions as CFO for NNE Pharmaplan and GN Resound. Holds 25,000 shares and stock options entitled to 157,334 shares, as of December 31 2016.
Research Interest
Interested in business
